88 related articles for article (PubMed ID: 21472273)
1. The MEK inhibitor PD98059 attenuates growth inhibition and death in gallic acid-treated Calu-6 lung cancer cells by preventing glutathione depletion.
Han YH; Moon HJ; You BR; Yang YM; Kim SZ; Kim SH; Park WH
Mol Med Rep; 2010; 3(3):519-25. PubMed ID: 21472273
[TBL] [Abstract][Full Text] [Related]
2. The effects of mitogen-activated protein kinase inhibitors or small interfering RNAs on gallic acid-induced HeLa cell death in relation to reactive oxygen species and glutathione.
You BR; Park WH
J Agric Food Chem; 2011 Jan; 59(2):763-71. PubMed ID: 21166414
[TBL] [Abstract][Full Text] [Related]
3. Gallic acid-induced lung cancer cell death is related to glutathione depletion as well as reactive oxygen species increase.
You BR; Park WH
Toxicol In Vitro; 2010 Aug; 24(5):1356-62. PubMed ID: 20417267
[TBL] [Abstract][Full Text] [Related]
4. MAPK inhibitors augment gallic acid-induced A549 lung cancer cell death through the enhancement of glutathione depletion.
Park WH; Kim SH
Oncol Rep; 2013 Jul; 30(1):513-9. PubMed ID: 23660987
[TBL] [Abstract][Full Text] [Related]
5. MAPK inhibitors differentially affect gallic acid-induced human pulmonary fibroblast cell growth inhibition.
Park WH
Mol Med Rep; 2011; 4(1):193-04. PubMed ID: 21461585
[TBL] [Abstract][Full Text] [Related]
6. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels.
Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
Anticancer Res; 2009 Oct; 29(10):3837-44. PubMed ID: 19846917
[TBL] [Abstract][Full Text] [Related]
7. The effects of MAPK inhibitors on pyrogallol-treated Calu-6 lung cancer cells in relation to cell growth, reactive oxygen species and glutathione.
Han YH; Moon HJ; You BR; Park WH
Food Chem Toxicol; 2010 Jan; 48(1):271-6. PubMed ID: 19833163
[TBL] [Abstract][Full Text] [Related]
8. The effects of N-acetyl cysteine, buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on antimycin A-treated Calu-6 lung cells in relation to cell growth, reactive oxygen species and glutathione.
Han YH; Park WH
Oncol Rep; 2009 Aug; 22(2):385-91. PubMed ID: 19578781
[TBL] [Abstract][Full Text] [Related]
9. Involvement of reactive oxygen species and glutathione in gallic acid-induced human umbilical vein endothelial cell death.
Park WH; Kim SH
Oncol Rep; 2012 Aug; 28(2):695-700. PubMed ID: 22665164
[TBL] [Abstract][Full Text] [Related]
10. Gallic acid inhibits the growth of HeLa cervical cancer cells via apoptosis and/or necrosis.
You BR; Moon HJ; Han YH; Park WH
Food Chem Toxicol; 2010 May; 48(5):1334-40. PubMed ID: 20197077
[TBL] [Abstract][Full Text] [Related]
11. The effects of MAPK inhibitors on antimycin A-treated calf pulmonary arterial endothelial cells in relation to cell death, reactive oxygen species and glutathione.
Han YH; You BR; Moon HJ; Kim SZ; Kim SH; Park WH
Mol Med Rep; 2010; 3(1):161-6. PubMed ID: 21472216
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of gallic acid-induced human pulmonary fibroblast cell death by N-acetyl cysteine and L-buthionine sulfoximine.
You BR; Park WH
Hum Exp Toxicol; 2011 Aug; 30(8):992-9. PubMed ID: 20921063
[TBL] [Abstract][Full Text] [Related]
13. MAPK inhibitors and siRNAs differentially affect cell death and ROS levels in arsenic trioxide-treated human pulmonary fibroblast cells.
Park WH
Oncol Rep; 2012 May; 27(5):1611-8. PubMed ID: 22293863
[TBL] [Abstract][Full Text] [Related]
14. Caspase inhibitor decreases apoptosis in pyrogallol-treated lung cancer Calu-6 cells via the prevention of GSH depletion.
Han YH; Kim SH; Kim SZ; Park WH
Int J Oncol; 2008 Nov; 33(5):1099-105. PubMed ID: 18949374
[TBL] [Abstract][Full Text] [Related]
15. Arsenic trioxide induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion.
You BR; Park WH
Oncol Rep; 2012 Aug; 28(2):749-57. PubMed ID: 22684917
[TBL] [Abstract][Full Text] [Related]
16. Enhanced cell death effects of MAP kinase inhibitors in propyl gallate-treated lung cancer cells are related to increased ROS levels and GSH depletion.
Park WH
Toxicol In Vitro; 2021 Aug; 74():105176. PubMed ID: 33865947
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of propyl gallate-induced calf pulmonary arterial endothelial cell death by MEK and JNK inhibitors.
Han YH; Kim SZ; Kim SH; Park WH
Mol Med Rep; 2009; 2(5):825-30. PubMed ID: 21475908
[TBL] [Abstract][Full Text] [Related]
18. MAPK inhibitors, particularly the JNK inhibitor, increase cell death effects in H2O2-treated lung cancer cells via increased superoxide anion and glutathione depletion.
Park WH
Oncol Rep; 2018 Feb; 39(2):860-870. PubMed ID: 29207156
[TBL] [Abstract][Full Text] [Related]
19. The effect of MAPK inhibitors and ROS modulators on cell growth and death of H₂O₂-treated HeLa cells.
Park WH
Mol Med Rep; 2013 Aug; 8(2):557-64. PubMed ID: 23799549
[TBL] [Abstract][Full Text] [Related]
20. p38 inhibitor enhances growth inhibition and death in gallic acid-treated endothelial cells.
Yang YM; Park WH
Int J Mol Med; 2010 Aug; 26(2):295-300. PubMed ID: 20596611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
